Bioceres Crop Solutions (BIOX) EBIT (2016 - 2026)

Bioceres Crop Solutions has disclosed EBIT across 11 years of filings, most recently posting -$4.3 million for Q1 2026.

• EBIT for Q1 2026 came in at -$4.3 million, down 200.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.5 million (down 114.18% YoY), and the FY2025 annual result was -$2.2 million, down 104.88% from the prior year.
• EBIT came in at -$4.3 million for Q1 2026 at Bioceres Crop Solutions, down from $7.5 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $29.9 million in Q1 2023 to a low of -$14.9 million in Q2 2025.
• The 5-year median for EBIT is $5.3 million (2023), against an average of $6.5 million.
• Across the five-year window, EBIT tumbled 248.68% in 2022 and jumped 1290.8% in 2023, its largest moves.
• Bioceres Crop Solutions' EBIT stood at $2.2 million in 2022, then jumped by 659.0% to $16.8 million in 2023, then fell by 14.71% to $14.4 million in 2024, then sank by 47.63% to $7.5 million in 2025, then tumbled by 157.16% to -$4.3 million in 2026.
• The last three EBIT figures came in at -$4.3 million (Q1 2026), $7.5 million (Q4 2025), and $7.2 million (Q3 2025), per Business Quant data.